Olanzapine- and clozapine-induced stuttering: A case series

Pharmacopsychiatry

Volumn 37, Issue 3, 2004, Pages 131-134

  Bar K J ^a,b   Hager F ^a   Sauer, H ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b Klinik für Strahlentherapie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; CLOZAPINE; DOXEPIN; HALOPERIDOL; LITHIUM; MORPHINE; NEUROLEPTIC AGENT; OLANZAPINE; PROMETHAZINE; RISPERIDONE; SERTRALINE; TRIMIPRAMINE; VALPROIC ACID; ZOPICLONE;

ADULT; AGED; AKATHISIA; ANAMNESIS; ARTICLE; BRAIN ATROPHY; BRAIN DISEASE; CELIAC DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL OBSERVATION; DEPRESSION; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FUNCTIONAL DISEASE; HOSPITAL PATIENT; HUMAN; MALE; MANIA; NEUROLOGIC EXAMINATION; OUTPATIENT; PAIN; PRIORITY JOURNAL; PUMP; SCHIZOPHRENIA; STUTTERING; SUICIDE ATTEMPT;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLOZAPINE; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; STUTTERING;

EID: 19244366033     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-818992     Document Type: Article

References (15)

1. Bhana N, Foster RH, Olney R, Plosker GL. Olanzapine: an updated review of its use in the management of schizophrenia. Drugs 2001; 61: 111-161
2. Brady JP. Drug-induced stuttering: a review of the literature. J Clin Psychopharmacol 1998; 18: 50-54
3. Burns D, Brady JP, Kuruvilla K. The acute effect of haloperidol and apomorphine on the severity of stuttering. Biol Psychiat 1978; 13: 255-264
4. Burns MJ. The pharmacology and toxicology of atypical antipsychotic agents. J Toxicol Clin Toxicol 2001; 39: 1-14
5. Ebeling TA, Compton AD, Albright DW. Clozapine-induced stuttering. Am J Psychiat 1997; 154: 1473
6. Eschweiler GW, Bartels M, Langle G, Wild B, Gaertner I, Nickola M. Heart-rate variability (HRV) in the ECG trace of routine EEGs: fast monitoring for the anticholinergic effects of clozapine and olanzapine?. Pharmacopsychiatry 2002; 35(3): 96-100
7. Friedman EH. Fluoxetine and stuttering. J Clin Psychiat 1990; 51: 310-311
8. Gaile S, Noviasky JA. Speech disturbance and marked decrease in function seen in several older patients on olanzapine. J Am Geriat Soc 1998; 46: 1330-1331
9. Horacek J. Novel antipsychotics and extrapyramidal side effects. Theory and reality. Pharmacopsychiatry 2000; 33: 24-42
10. Kent RD. Research on speech motor control and its disorders: a review and prospective. J Commun Disord 2000; 33: 391-427
11. Lee HJ, Lee HS, Kim L, Lee MS, Suh KY, Kwak DI. A case of risperidone-induced stuttering. J Clin Psychopharmacol 2001; 21: 115-116
12. Maguire GA, Riley GD, Franklin DL, Gottschalk LA. Risperidone for the treatment of stuttering. J Clin Psychopharmacol 2000; 20: 479-482
13. Marsalek M. Tardive drug-induced extrapyramidal syndromes. Pharmacopsychiatry, 2000: 14-33
14. Menkes DB, Ungvari GS. Adult-onset stuttering as a presenting feature of schizophrenia: restoration of fluency with trifluoperazine. J Nerv Ment Dis 1993; 181: 64-65
15. Thomas P, Lalaux N, Vaiva G, Goudemand M. Dose-dependent stuttering and dystonia in a patient taking clozapine. Am J Psychiat 1994; 151: 1096